Diagnamed Holdings (XCNQ:DMED) Debt-to-Equity : 0.00 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings Debt-to-Equity?

Diagnamed Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$0.00 Mil. Diagnamed Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$0.00 Mil. Diagnamed Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2024 was C$-0.29 Mil. Diagnamed Holdings's debt to equity for the quarter that ended in Dec. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Diagnamed Holdings's Debt-to-Equity or its related term are showing as below:

XCNQ:DMED's Debt-to-Equity is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.44
* Ranked among companies with meaningful Debt-to-Equity only.

Diagnamed Holdings Debt-to-Equity Historical Data

The historical data trend for Diagnamed Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings Debt-to-Equity Chart

Diagnamed Holdings Annual Data

Trend

Sep21

Sep22

Sep23

Sep24

Debt-to-Equity

Diagnamed Holdings Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Diagnamed Holdings's Debt-to-Equity

For the Health Information Services subindustry, Diagnamed Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnamed Holdings's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Diagnamed Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Diagnamed Holdings's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.265
	=	0.00

Diagnamed Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.293
	=	0.00

Diagnamed Holdings (XCNQ:DMED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Diagnamed Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnamed Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DGNMF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.diagnamed.com

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.

Executives

Fabio Chianelli

Director, Senior Officer

Diagnamed Holdings Headlines

No Headlines